Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1982 Mar;69(3):722–725. doi: 10.1172/JCI110501

Evidence for extrarenal production of 1 alpha ,25-dihydroxyvitamin D in man.

P W Lambert, P H Stern, R C Avioli, N C Brackett, R T Turner, A Greene, I Y Fu, N H Bell
PMCID: PMC371031  PMID: 6895901

Abstract

Recent studies provide evidence for extrarenal production of 1 alpha ,25-dihydroxyvitamin D [1 alpha ,25(OH)2D]. To investigate this possibility, serum vitamin D, 25-hydroxyvitamin D (25-OHD), 24,25-dihydroxyvitamin D [24,25(OH)2D], and 1 alpha ,25(OH)2D were measured in eight adult anephric subjects. All were undergoing hemodialysis and three of them were receiving vitamin D, 50,000 or 100,000 U/d. Serum vitamin D was elevated in two of the patients given vitamin D and was abnormally low in the others. Mean serum 25-OHD was increased in patients given vitamin D (94.0 +/- 7.6 ng/ml) and was normal in the others (16.4 +/- 0.9 ng/ml, P less than 0.001). Mean serum 24,25(OH)2D was normal in patients given vitamin D (1.38 +/- 0.27 ng/ml) and was low in the others (0.25 +/- 0.08 ng/ml, P less than 0.001). Serum 24,25(OH)2D correlated significantly with serum 25-OHD (r = 0.848, P less than 0.01). Mean serum 1 alpha ,25(OH)2D determined by receptor assay was 5.8 +/- 1.9 pg/ml in patients who were not given vitamin D and was 14.1 +/- 0.6 in those who were given vitamin D (P less than 0.001). Serum 1 alpha ,25(OH)2D correlated significantly with serum 25-OHD (r = 0.911, P less than 0.01). Mean serum 1 alpha ,25(OH)2D, measured by bioassay, was 8.3 +/- 1.9 pg/ml in patients who were given vitamin D and was 15.9 +/- 2.4 pg/ml in those who were given vitamin D (P less than 0.05). There was a significant correlation between the values for serum 1 alpha ,25(OH)2D obtained with the two methods (r = 0.728, P less than 0.01). The results (a) provide evidence in man for extrarenal production of both 24,25(OH)2D and, by two independent assays, of 1 alpha , 25(OH)2D, and (b) indicate that serum values of the two dihydroxy metabolites of vitamin D in anephric subjects vary with the serum concentration of the precursor 25-OHD.

Full text

PDF
722

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baginski E. S., Marie S. S., Clark W. L., Zak B. Direct microdetermination of serum calcium. Clin Chim Acta. 1973 Jun 14;46(1):49–54. doi: 10.1016/0009-8981(73)90101-0. [DOI] [PubMed] [Google Scholar]
  2. Barbour G. L., Coburn J. W., Slatopolsky E., Norman A. W., Horst R. L. Hypercalcemia in an anephric patient with sarcoidosis: evidence for extrarenal generation of 1,25-dihydroxyvitamin D. N Engl J Med. 1981 Aug 20;305(8):440–443. doi: 10.1056/NEJM198108203050807. [DOI] [PubMed] [Google Scholar]
  3. Bouillon R., De Moor P., Baggiolini E. G., Uskokovic M. R. A radioimmunoassay for 1,25-dihydroxycholecalciferol. Clin Chem. 1980 Apr;26(5):562–567. [PubMed] [Google Scholar]
  4. Clemens T. L., Hendy G. N., Papapoulos S. E., Fraher L. J., Care A. D., O'Riordan J. L. Measurement of 1,25-dihydroxycholecalciferol in man by radioimmunoassay. Clin Endocrinol (Oxf) 1979;11(2):225–234. doi: 10.1111/j.1365-2265.1979.tb03068.x. [DOI] [PubMed] [Google Scholar]
  5. Horst R. L., Littledike E. T., Gray R. W., Napoli J. L. Impaired 24,25-dihydroxyvitamin D production in anephric human and pig. J Clin Invest. 1981 Jan;67(1):274–280. doi: 10.1172/JCI110023. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Horst R. L., Shepard R. M., Jorgensen N. A., DeLuca H. F. The determination of 24,25-dihydroxyvitamin D and 25,26-dihydroxyvitamin D in plasma from normal and nephrectomized man. J Lab Clin Med. 1979 Feb;93(2):277–285. [PubMed] [Google Scholar]
  7. Howard G. A., Turner R. T., Sherrard D. J., Baylink D. J. Human bone cells in culture metabolize 25-hydroxyvitamin D3 to 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3. J Biol Chem. 1981 Aug 10;256(15):7738–7740. [PubMed] [Google Scholar]
  8. Jongen M. J., van der Vijgh W. J., Willems H. J., Netelenbos J. C. Analysis for 1,25-dihydroxyvitamin D in human plasma, after a liquid-chromatographic purification procedure, with a modified competitive protein-binding assay. Clin Chem. 1981 Mar;27(3):444–450. [PubMed] [Google Scholar]
  9. Kano K., Nonoda A., Yoneshima H., Suda T. Serum concentrations of 25-hydroxyvitamin D and 24,25-dihydroxyvitamin D in patients with various types of renal disease. Clin Nephrol. 1980 Dec;14(6):274–279. [PubMed] [Google Scholar]
  10. Lambert P. W., DeOreo P. B., Hollis B. W., Fu I. Y., Ginsberg D. J., Roos B. A. Concurrent measurement of plasma levels of vitamin D3 and five of its metabolites in normal humans, chronic renal failure patients, and anephric subjects. J Lab Clin Med. 1981 Oct;98(4):536–548. [PubMed] [Google Scholar]
  11. Lambert P. W., Hollis B. W., Bell N. H., Epstein S. Demonstration of a lack of change in serum 1 alpha,25-dihydroxyvitamin D in response to parathyroid extract in pseudohypoparathyroidism. J Clin Invest. 1980 Oct;66(4):782–791. doi: 10.1172/JCI109916. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Lund B., Sørensen O. H., Lund B., Bishop J. E., Norman A. W. Vitamin D metabolism in hypoparathyroidism. J Clin Endocrinol Metab. 1980 Sep;51(3):606–610. doi: 10.1210/jcem-51-3-606. [DOI] [PubMed] [Google Scholar]
  13. Shepard R. M., Horst R. L., Hamstra A. J., DeLuca H. F. Determination of vitamin D and its metabolites in plasma from normal and anephric man. Biochem J. 1979 Jul 15;182(1):55–69. doi: 10.1042/bj1820055. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Stern P. H. A monolog on analogs: in vitro effects of vitamin D metabolites and consideration of the mineralization question. Calcif Tissue Int. 1981;33(1):1–4. doi: 10.1007/BF02409404. [DOI] [PubMed] [Google Scholar]
  15. Stern P. H., Phillips T. E., Mavreas T. Bioassay of 1,25-dihydroxyvitamin D in human plasma purified by partition, alkaline extraction, and high-pressure chromatography. Anal Biochem. 1980 Feb;102(1):22–30. doi: 10.1016/0003-2697(80)90311-5. [DOI] [PubMed] [Google Scholar]
  16. Tanaka Y., Halloran B., Schnoes H. K., DeLuca H. F. In vitro production of 1,25-dihydroxyvitamin D3 by rat placental tissue. Proc Natl Acad Sci U S A. 1979 Oct;76(10):5033–5035. doi: 10.1073/pnas.76.10.5033. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Taylor C. M., Mawer E. B., Wallace J. E., St John J., Cochran M., Russell R. G., Kanis J. A. The absence of 24,25-dihydroxycholecalciferol in anephric patients. Clin Sci Mol Med Suppl. 1978 Dec;55(6):541–547. doi: 10.1042/cs0550541. [DOI] [PubMed] [Google Scholar]
  18. Turner R. T., Puzas J. E., Forte M. D., Lester G. E., Gray T. K., Howard G. A., Baylink D. J. In vitro synthesis of 1 alpha,25-dihydroxycholecalciferol and 24,25-dihydroxycholecalciferol by isolated calvarial cells. Proc Natl Acad Sci U S A. 1980 Oct;77(10):5720–5724. doi: 10.1073/pnas.77.10.5720. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Weisman Y., Harell A., Edelstein S., David M., Spirer Z., Golander A. 1 alpha, 25-Dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3 in vitro synthesis by human decidua and placenta. Nature. 1979 Sep 27;281(5729):317–319. doi: 10.1038/281317a0. [DOI] [PubMed] [Google Scholar]
  20. Wiske P. S., Epstein S., Bell N. H., Queener S. F., Edmondson J., Johnston C. C., Jr Increases in immunoreactive parathyroid hormone with age. N Engl J Med. 1979 Jun 21;300(25):1419–1421. doi: 10.1056/NEJM197906213002506. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES